MINGCHEN HEALTH(002919)2023-10-29 16:00Financial Performance - The company's revenue for Q3 2023 reached ¥458,654,304.96, representing a 109.97% increase compared to the same period last year[5]. - Net profit attributable to shareholders for Q3 2023 was ¥66,229,524.81, a significant increase of 245.47% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥64,181,120.95, up 240.70% from the previous year[5]. - The company reported a 131.47% increase in total revenue for the first nine months of 2023, totaling ¥1,303,240,197.69[12]. - Total operating revenue for the period reached CNY 1,303,240,197.69, a significant increase from CNY 563,016,929.22 in the previous period, representing a growth of approximately 131.1%[22]. - Net profit attributable to shareholders of the parent company was CNY 165,872,454.96, compared to a net loss of CNY 18,380,380.51 in the same period last year[24]. - Basic and diluted earnings per share were both CNY 0.75, a recovery from a loss of CNY 0.08 per share in the previous period[24]. Assets and Liabilities - The total assets as of September 30, 2023, amounted to ¥1,357,952,986.81, reflecting a 9.25% increase from the end of the previous year[5]. - The company’s total equity attributable to shareholders increased by 22.44% to ¥905,120,335.50 compared to the end of the previous year[5]. - Total current assets reached CNY 847,407,758.62, up from CNY 638,873,323.41, showing improved liquidity[20]. - The total liabilities decreased to CNY 452,832,651.31 from CNY 503,785,314.45, showing improved financial stability[21]. - Total equity attributable to shareholders of the parent company increased to CNY 905,120,335.50 from CNY 739,247,880.54, reflecting a stronger balance sheet[21]. Cash Flow - Operating cash flow net amount for the year-to-date was -¥14,023,730.20, an improvement of 84.74% compared to the same period last year[14]. - The net cash flow from operating activities for Q3 2023 was -14,023,730.20, compared to -91,884,294.74 in Q3 2022, indicating an improvement[26]. - Total cash inflow from operating activities was 1,112,457,313.85, while cash outflow was 1,126,481,044.05, resulting in a net cash flow of -14,023,730.20[26]. - The net cash flow from investing activities was -5,125,932.95, compared to 10,591,723.32 in Q3 2022, reflecting a decline[26]. - The net cash flow from financing activities was -20,487,383.09, compared to -49,724,015.09 in Q3 2022, showing an improvement[26]. Shareholder Information - The top shareholder, Chen Qinfang, holds 35.01% of the shares, totaling 77,782,170 shares[16]. - The second-largest shareholder, Liu Xiaowei, owns 9.36% of the shares, amounting to 20,787,390 shares[16]. - The company has a total of 8,793 common shareholders as of the reporting date[16]. - The total number of preferred shareholders is reported as zero, indicating no preferred shares outstanding[18]. Expenses - Sales expenses surged by 639.58% to ¥496,690,001.13, driven by the expansion of the gaming publishing business[12]. - Research and development expenses totaled CNY 87,666,455.91, up from CNY 77,079,189.10, indicating a focus on innovation and product development[23]. - Sales expenses surged to CNY 496,690,001.13 from CNY 67,158,378.58, highlighting increased marketing efforts[23]. Inventory and Receivables - Accounts receivable increased by 140.41% to ¥387,626,521.61, primarily due to revenue growth in the gaming sector[10]. - Inventory rose to CNY 202,909,810.33 compared to CNY 191,289,119.65, reflecting an increase in stock levels[20]. - Accounts receivable increased to CNY 387,626,521.61 from CNY 161,235,530.85, indicating a significant growth in sales or credit terms[20]. Audit and Tax - The company did not undergo an audit for the Q3 2023 report[28]. - The company received tax refunds amounting to 29,189.22 in Q3 2023[26].